Need a specific person's email?
Browse Guerbet's employee directory (about 2.5K employees) and reveal verified emails free.
Guerbet's most common email format is First.Last@guerbet.com (ex. John.Doe@guerbet.com), used for 93% of guerbet.com addresses. Guerbet uses 8 email patterns across 2 domains: guerbet.com and guerbet-group.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of guerbet.com |
|---|---|---|
| First.Last@guerbet.comMost common | John.Doe@guerbet.com | |
| FLast@guerbet.com | JDoe@guerbet.com | |
| First@guerbet.com | John@guerbet.com | |
| FirstLast@guerbet.com | JohnDoe@guerbet.com |
| Format | Example | Share of guerbet-group.com |
|---|---|---|
| First.Last@guerbet-group.comMost common | John.Doe@guerbet-group.com | |
| LastF@guerbet-group.com | DoeJ@guerbet-group.com | |
| FLast@guerbet-group.com | JDoe@guerbet-group.com | |
| First.Middle@guerbet-group.com | John.Michael@guerbet-group.com |
Browse Guerbet's employee directory (about 2.5K employees) and reveal verified emails free.
Pharmaceutical ManufacturingÎle-de-France, France1001-5000 Employees
Guerbet is a pharmaceutical manufacturing company headquartered at 15 Rue Des Vanesses Zone Paris Nord ii Villepinte, Île-de-france, France. It is described as a global leader in medical imaging, offering a portfolio that includes pharmaceutical products, medical devices, and AI-driven solutions for diagnostic and interventional imaging. With nearly a century of expertise, Guerbet maintains dedicated innovation centers in France and the United States and commits about 9% of its annual revenue to research and development. The company employs between 1,001 and 5,000 people. Reported revenue ranges from $1B to $10B, with funding listed at $962K, and the company maintains a website at https://guerbet.com.
Most common format
First.Last@guerbet.com
Example: John.Doe@guerbet.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.